About CERo Therapeutics Holdings Inc. CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its ...

Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...

US appeals court blocks Trump admin from enacting new plans to slash consumer watchdog staff A federal appeals court on Friday blocked the Trump administration's plans to immediately slash the ...

Short interest is the volume of CERo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 192,900 shares of CERO short. 16 ...

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for CERo Therapeutics is $30.00, with a high forecast of $30.00 and a low ...

Get the latest news and real-time alerts from CERo Therapeutics Holdings, Inc. (CERO) stock at Seeking Alpha.

The Closure Compiler is a tool for making JavaScript download and run faster. It is a true compiler for JavaScript. Instead of compiling from a source language to machine code, it compiles from ...